Nick is a partner in our life sciences and chemistry team in London.
His practice concentrates on pharmaceutical chemistry, regenerative medicine, immunotherapy, genome mapping and synthetic genome assembly. He has been significantly involved in patent applications relating to cloning (somatic cell nuclear transfer), stem cells, cancer immunotherapy / CAR-T cells, regenerative medicine, gene therapy, and monoclonal antibodies / novel antigen receptor proteins (IgNARs/VNARs). Additionally, he brings deep involvement in patent applications relating to controlled release / sustained release pharmaceutical formulations, genetic diagnosis, biomarkers and synthetic biology.
Experience has provided Nick with an insight into intellectual property issues of research institutions, pharmaceutical and biotechnology companies.
His practice ranges from drafting original patent applications and devising filing strategies, to advising on intellectual property aspects of company mergers and acquisitions, including due diligence on intellectual property rights.
His European portfolio includes post-grant opposition proceedings at the EPO, contentious proceedings in other foreign jurisdictions, as well as obtaining Supplementary Protection Certificates for pharmaceuticals.
Nick’s memberships include: Chartered Institute of Patent Attorneys (CIPA), European Patent Office (EPI), International Association for the Protection of Intellectual Property (AIPPI), International Federation of Intellectual Property Attorneys (FICPI), The Intellectual Property Lawyers' Organisation (TIPLO), and The Biochemical Society
IAM patent 2019 says that 'Nick Bassil combines his “outstanding prosecution practice” in the life sciences and chemistry arenas with strategic adroitness in post-grant EPO proceedings.'
Nick Bassil combines his “outstanding prosecution practice” in the life sciences and chemistry arenas with strategic adroitness in post-grant EPO proceedings.' - IAM patent, 2019
Nick is ‘experienced at all stages of patent matters and is particularly recommended for stem cells and regenerative medicine related matters’ - The Legal 500, 2017
Nick ‘is sought after for his SPC knowledge and understanding of stem cells and regenerative medicine’. - IAM Patent 1000, 2017
Nick has been recognised for his handling of 'a massive portfolio for International Stem Cell Corporation' and his success securing a decision for them before the European Court of Justice. - IAM Patent 1000, 2016
Nick is individually ranked in band 1, Patent Attorneys, Chambers and Partners 2016. 'Nick Bassil is experienced at all stages of patent matters, from drafting through filing to oppositions. He specialises in life science.' - Chambers and Partners, 2016
Managing IP has acknowledged Nick as an ‘IP Star’ for Patents in their 2014, 2015 and 2016 IP Stars Handbook.
Nick is acknowledged as a 'pharmacology and biochemistry master’ who plays a 'key role' in the chemistry and life sciences arenas. Nick has also been ‘Recommended’ for ‘Individuals - prosecution’. - IAM Patent 1000, 2015
Nick has been named as an expert in his field. - Patents expert guide, 2015
Nick has been called a 'star player' and acknowledged for his commercial approach. Nick has also been 'Recommended' for 'Individuals - prosecution.' - IAM Patent 1000, 2014
European Patent Attorney (1999)
Chartered UK Patent Attorney (1998)
European Design Attorney
IP Litigator - Patent
MSc in Management of Intellectual Property (1992) from Queen Mary College, University of London.
MSc thesis (1992) on "Molecular characterisation of the endocytic pathway using the fission yeast Schizosaccaromyces pombe" from the University of Birmingham
BSc honours degree in Biochemistry (1988) from the University of Birmingham
Chartered Institute of Patent Attorneys (CIPA)
European Patent Office (EPI)
International Association for the Protection of Intellectual Property (AIPPI)
International Federation of Intellectual Property Attorneys (FICPI)
The Intellectual Property Lawyers' Organisation (TIPLO)
The Biochemical Society
N. Bassil, J. Duncombe, Patentability of plant products obtained by an essentially biological process, Kilburn & Strode, (2019)
N. Bassil, K.Cornish, N. Lee, T. Leonard, Protecting the protector: The intersection of IP and Immuno-Oncology, Kilburn & Strode, (2019)
'An introduction to international IP instruments relevant to life sciences’, Intellectual Property in the Life Sciences, Part 1 Chapter 1, Global Law & Business, (2nd edition, 2015)
‘An introduction to international IP instruments relevant to electronics and software’, Intellectual Property in Electronics and Software, Part 1, Chapter 1, Globe Law & Business (2013)
‘Practical implications of the unitary patent system in Europe’, Pharmaceutical Patent Analyst 2(5), 585-590 (2013)
'An introduction to international IP instruments relevant to life sciences’, Intellectual Property in the Life Sciences, Part 1 Chapter 1, Global Law & Business, (2011)
‘Developments in the patentability of inventions relating to human embryonic stem cells’, Bio-Science Law Review, volume 12 (1), pages 3-7 (2011)
'Regenerative Medicine European Court to rule on stem cell patents’, Mednous, volume 5, (5), page 20, May 2011